Clinical Trial

Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours

Study acronym: HyBT-H&N
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 8, 2018 (before its estimated December 31, 2022 completion). Its status may not reflect the trial's current state.
Summary
The aim of the present trial is to assess the prospective results of protocol-based interstitial pulsed-dose-rate (PDR) brachytherapy with interstitial hyperthermia (iHT) in a group of selected patients where salvage surgery with clear resection margins was not possible.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2017-07-31.
Trial Details
NCT Number NCT03238378
Lead Sponsor University of Erlangen-Nürnberg Medical School
Conditions Locally Recurrent Head and Neck Cancer
Enrollment 96 participants
Start Date 2017-03-29
Primary Completion 2022-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2018-06-08